1415045-22-5Relevant articles and documents
TRICYCLIC AKR1C3 DEPENDENT KARS INHIBITORS
-
Page/Page column 76, (2021/01/29)
The present invention relates to novel tricyclic compounds that are AKR1C3 dependent KARS inhibitor, processes for their preparation, pharmaceutical compositions, and medicaments containing them, and their use in diseases and disorders mediated by an AKR1C3 dependent KARS inhibitor.
HETEROCYCLIC COMPOUND AS CSF-1R INHIBITOR AND USE THEREOF
-
Paragraph 0104; 0105, (2020/11/23)
The present invention relates to a class of isoindolinone derivatives and use thereof in the preparation of a medicament for treating diseases associated with a novel colony stimulating factor 1 receptor (CSF-1R) inhibitor. In particular, the present invention relates to a compound of formula (I) and a pharmaceutically acceptable salt thereof or a stereoisomer thereof.